[13] However, if you feel like youre experiencing Wegovy depression side effects (or relating to another GLP-1 medication), including new or worsening depression, suicidal thoughts, or unusual changes in mood or behavior, reach out for support
Not all payers have readily available coverage policies and there is no consistency across payers, so reimbursement is not certain
However, their translation to clinical practice hinges on addressing critical gaps, including the need for rigorous human trials, long-term safety assessments, and mechanistic clarity
Brain 146 , 31923205 (2023)
Recent studies show that GLP-1(936) can activate the inhibitory G protein (Gi/o), leading to the translocation of secretory granules (SG) beneath the cell membrane, thereby inhibiting glucagon secretion.241 This mechanism is unaffected by genetic or pharmaceutical inhibition of GLP-1R, but it is sensitive to pertussis toxin
weight loss (Phase 2/3 peak) | ~15% | ~22% | ~24% | | FDA Status | Approved (Wegovy, Ozempic) | Approved (Zepbound, Mounjaro) | Phase 3 (2026) | | Dosing frequency | Weekly | Weekly | Weekly | The additional glucagon receptor agonism is believed to be responsible for retatrutide's greater metabolic rate increase and enhanced fat oxidation compared to dual agonists
